nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Intestinal obstruction—Topotecan—peripheral nervous system neoplasm	0.0301	0.0301	CcSEcCtD
Sevelamer—Faecaloma—Epirubicin—peripheral nervous system neoplasm	0.0236	0.0236	CcSEcCtD
Sevelamer—Faecalith—Epirubicin—peripheral nervous system neoplasm	0.0236	0.0236	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—peripheral nervous system neoplasm	0.0218	0.0218	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—peripheral nervous system neoplasm	0.0218	0.0218	CcSEcCtD
Sevelamer—Intestinal obstruction—Vincristine—peripheral nervous system neoplasm	0.0218	0.0218	CcSEcCtD
Sevelamer—Ileus—Vincristine—peripheral nervous system neoplasm	0.021	0.021	CcSEcCtD
Sevelamer—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Sevelamer—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Sevelamer—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.00973	0.00973	CcSEcCtD
Sevelamer—Ileus—Epirubicin—peripheral nervous system neoplasm	0.00952	0.00952	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—peripheral nervous system neoplasm	0.00881	0.00881	CcSEcCtD
Sevelamer—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00875	0.00875	CcSEcCtD
Sevelamer—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00875	0.00875	CcSEcCtD
Sevelamer—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00762	0.00762	CcSEcCtD
Sevelamer—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00756	0.00756	CcSEcCtD
Sevelamer—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00756	0.00756	CcSEcCtD
Sevelamer—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00697	0.00697	CcSEcCtD
Sevelamer—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00691	0.00691	CcSEcCtD
Sevelamer—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00691	0.00691	CcSEcCtD
Sevelamer—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00666	0.00666	CcSEcCtD
Sevelamer—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00663	0.00663	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0066	0.0066	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.0066	0.0066	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00652	0.00652	CcSEcCtD
Sevelamer—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00643	0.00643	CcSEcCtD
Sevelamer—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00638	0.00638	CcSEcCtD
Sevelamer—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00638	0.00638	CcSEcCtD
Sevelamer—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00635	0.00635	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00631	0.00631	CcSEcCtD
Sevelamer—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Sevelamer—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Sevelamer—Fatigue—Topotecan—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Sevelamer—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00626	0.00626	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00626	0.00626	CcSEcCtD
Sevelamer—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00625	0.00625	CcSEcCtD
Sevelamer—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00625	0.00625	CcSEcCtD
Sevelamer—Constipation—Topotecan—peripheral nervous system neoplasm	0.00625	0.00625	CcSEcCtD
Sevelamer—Pain—Topotecan—peripheral nervous system neoplasm	0.00625	0.00625	CcSEcCtD
Sevelamer—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00622	0.00622	CcSEcCtD
Sevelamer—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Sevelamer—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Sevelamer—Pain—Tretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Sevelamer—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00618	0.00618	CcSEcCtD
Sevelamer—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00617	0.00617	CcSEcCtD
Sevelamer—Pain—Melphalan—peripheral nervous system neoplasm	0.00612	0.00612	CcSEcCtD
Sevelamer—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00598	0.00598	CcSEcCtD
Sevelamer—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Sevelamer—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Sevelamer—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00578	0.00578	CcSEcCtD
Sevelamer—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Sevelamer—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Sevelamer—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Sevelamer—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00565	0.00565	CcSEcCtD
Sevelamer—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00565	0.00565	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.0054	0.0054	CcSEcCtD
Sevelamer—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Sevelamer—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Sevelamer—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Sevelamer—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Sevelamer—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00517	0.00517	CcSEcCtD
Sevelamer—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00515	0.00515	CcSEcCtD
Sevelamer—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Sevelamer—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Sevelamer—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Sevelamer—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00511	0.00511	CcSEcCtD
Sevelamer—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00507	0.00507	CcSEcCtD
Sevelamer—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00506	0.00506	CcSEcCtD
Sevelamer—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Sevelamer—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.005	0.005	CcSEcCtD
Sevelamer—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00496	0.00496	CcSEcCtD
Sevelamer—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00496	0.00496	CcSEcCtD
Sevelamer—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0049	0.0049	CcSEcCtD
Sevelamer—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Sevelamer—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00484	0.00484	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00482	0.00482	CcSEcCtD
Sevelamer—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00474	0.00474	CcSEcCtD
Sevelamer—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00474	0.00474	CcSEcCtD
Sevelamer—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Sevelamer—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Sevelamer—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00468	0.00468	CcSEcCtD
Sevelamer—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Sevelamer—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Sevelamer—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Sevelamer—Rash—Topotecan—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Sevelamer—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0046	0.0046	CcSEcCtD
Sevelamer—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.0046	0.0046	CcSEcCtD
Sevelamer—Rash—Tretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Sevelamer—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Sevelamer—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Sevelamer—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Sevelamer—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Sevelamer—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Sevelamer—Constipation—Vincristine—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Sevelamer—Pain—Vincristine—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Sevelamer—Rash—Melphalan—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Sevelamer—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Sevelamer—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00449	0.00449	CcSEcCtD
Sevelamer—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Sevelamer—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Sevelamer—Nausea—Topotecan—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Sevelamer—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Sevelamer—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Sevelamer—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Sevelamer—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Sevelamer—Nausea—Melphalan—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Sevelamer—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00419	0.00419	CcSEcCtD
Sevelamer—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00409	0.00409	CcSEcCtD
Sevelamer—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Sevelamer—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00405	0.00405	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Sevelamer—Pain—Cisplatin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Sevelamer—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Sevelamer—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Sevelamer—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Sevelamer—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Sevelamer—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Sevelamer—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Sevelamer—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Sevelamer—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Sevelamer—Constipation—Etoposide—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Sevelamer—Pain—Etoposide—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Sevelamer—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Sevelamer—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Sevelamer—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Sevelamer—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Sevelamer—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Sevelamer—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Sevelamer—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00339	0.00339	CcSEcCtD
Sevelamer—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Sevelamer—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Sevelamer—Rash—Vincristine—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Sevelamer—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Sevelamer—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Sevelamer—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Sevelamer—Nausea—Vincristine—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Sevelamer—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Sevelamer—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Sevelamer—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Sevelamer—Rash—Cisplatin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Sevelamer—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Sevelamer—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Sevelamer—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Sevelamer—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Sevelamer—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Sevelamer—Rash—Etoposide—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Sevelamer—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Sevelamer—Nausea—Etoposide—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Sevelamer—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Sevelamer—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Sevelamer—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Sevelamer—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Sevelamer—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Sevelamer—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Sevelamer—Pain—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Sevelamer—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Sevelamer—Pain—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Sevelamer—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Sevelamer—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Sevelamer—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Sevelamer—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Sevelamer—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Sevelamer—Rash—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Sevelamer—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Sevelamer—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Sevelamer—Rash—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
